NEW DELHI: Vaccine maker Serum Institute of India (SII) on Friday said the precaution dose of its Covishield vaccine against Covid-19 will be priced at Rs 600 per shot for eligible individuals. SII CEO Adar Poonawalla also welcomed the government’s move to allow precaution dose of the vaccine to all aged above 18 years at…Continue Reading

India’s Serum Institute exports first Novavax shot

A vial and a syringe are seen in front of a displayed Novavax logo, in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/IllustrationNEW DELHI, Dec 1 (Reuters) – (This Nov. 30 story has been officially corrected to remove reference to COVAX from headline and lead after Indian government clarifies it was a bilateral deal between…Continue Reading

Serum Institute of India seeks regular marketing authorisation from DCGI for Covishield

 Pointing out that over 100 crore doses of Covishield have been supplied in India and many other countries, Serum Institute of India on Monday sought regular marketing approval for the COVID-19 vaccine, which is currently authorized for emergency use in the country, official sources said. The application sent to the Drugs Controller General of India…Continue Reading